FRIDAY, Jan. 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved a second Alzheimer’s drug, lecanemab, despite reports of rare brain bleeds linked to use of the drug in some patients. However, the FDA pointed to the drug’s benefits, as well. “Alzheimer’s disease immeasurably incapacitatesContinue Reading

FRIDAY, Jan. 6, 2023 (HealthDay News) — Patients with an incurable, genetic liver disease have new hope after an animal study showed that a single drug could reverse its effects. Alagille syndrome is caused by a mutation that prevents the formation and regeneration of bile ducts in the liver. AboutContinue Reading

THURSDAY, Jan. 5, 2023 (HealthDay News) — Lecanemab: It’s an experimental medication that’s been shown in trials to slow cognitive decline in people with Alzheimer’s disease. It’s also up for accelerated approval by the U.S. Food and Drug Administration, with a decision expected by Jan. 6. However, the drug hasContinue Reading

THURSDAY, Jan. 5, 2023 (HealthDay News) – Researchers studying patients with low-grade, slow-growing brain tumors have found that more aggressive surgery may extend survival. The trick to treating low-grade gliomas is to remove as much of them as possible soon after diagnosis, researchers at University of California, San Francisco found.Continue Reading

WEDNESDAY, Dec. 28, 2022 (HealthDay News) — Insured Black patients are less likely to undergo minimally invasive heart valve replacement or repairs — relatively safe procedures — than their white counterparts, new research shows. Black patients who need a mitral valve replacement are more likely to have operations that involveContinue Reading